• COVID-19 Resources
  • About
  • Subscribe
  • Promotions
  • Advertise
  • Contact Us
  • July 4, 2025

Milwaukee Courier Weekly Newspaper

"THE NEWSPAPER YOU CAN TRUST SINCE 1964"

  • News
  • Editorials
  • Education
  • Urban Business
  • Health
  • Religion
  • Upcoming Events
  • Classifieds
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MILWAUKEE COURIER

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

No, Pharmaceutical Companies Are Not “War Profiteers”

December 4, 2021

By Charles Boustany

Charles Boustany is a retired physician and former congressman from Louisiana.

Scientists developed COVID-19 vaccines at an unprecedented speed, and distribution has by some measures been wildly successful. Less than a year after the first approvals, over half of the world’s population has had at least a first shot.

And yet, while over 70% of people in the highest-income countries have received a dose, that figure is only 5% in the lowest-income countries. For both moral and practical reasons, we need to urgently fix this gap.

As we look for solutions, some blame vaccine makers themselves. It should perhaps come as no surprise that people with little knowledge of science, economics or the drug industry would take this view. But it’s shocking to hear someone like Tom Frieden, former director of the Centers for Disease Control and Prevention, espouse this particular brand of criticism. In an October tweet, Frieden accused vaccine makers Pfizer and Moderna of “war profiteering” for “failing to share their technology.”

Such claims are outrageous. No serious person believes that these companies are profiting unreasonably or that suspending IP rights would do anything to get shots in arms more quickly.

Consider, first, the claim that these companies are profiting unreasonably. The world’s poorest nations are receiving donated vaccines; wealthy nations are paying “about the cost of a takeaway meal” for each injection, to quote Pfizer CEO Albert Bourla, and middle-income countries are paying about half of that. Low-income nations that are purchasing the vaccines are receiving them at cost.

Frieden’s point on technology sharing is equally disingenuous. Critics like Frieden suggest that if pharmaceutical companies would just give away the intellectual property behind their vaccines – “share their technology,” as he put it – more companies could immediately start producing shots, thus ending the pandemic.

If only.

First of all, vaccine manufacturing facilities are already running at capacity, and facing shortages of staff and raw materials. So just handing over trade secrets would do nothing to immediately increase supply.

More importantly, advocates for ending IP rights misrepresent how our system actually works.

It may be fashionable to vilify companies for seeking to make a profit. But the fact is, private investment, risk-taking, and the chance to make a return are crucial to the drug development process. No one would invest if they knew governments could nullify the IP protections that prevent the end product from being stolen. But thanks to these laws, the biopharmaceutical industry delivers new and better drugs every year for killers like heart disease, Alzheimer’s and cancer. Not to mention vaccines against novel deadly viruses.

We hear a lot about Pfizer-BioNTech, Moderna, and Johnson & Johnson because they brought vaccines to the U.S. market. But other pharmaceutical companies also tried. At least seven vaccines went through trials but were subsequently abandoned. Merck discontinued research on its candidates in January. GlaxoSmithKline only just entered a Phase III trial.

In short, there were no guarantees of success, financial or otherwise. We got vaccines because investors and companies took chances. And no one is going to take those chances in the future if we do away with IP law.

Health care leaders are right to lament the inequities in vaccine distribution. But vilifying medical innovators with absurd comparisons doesn’t help anyone. The companies that developed vaccines in record time are ending the war against COVID-19. And getting rid of IP protections on drugs would have deadly consequences in the long run.

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Popular Interests In This Article: Charles Boustany, COVID-19 Vaccine

Read More - Related Articles

  • Fact or Fiction: Addressing and Correcting Misinformation about COVID-19 Vaccines
  • Here’s What you Need to Know About Medical Costs Once the Public Health Emergency ends
  • Black History Month and Vaccinations
  • FREE Community Covid Vaccination Clinic at Northcott Neighborhood House
  • The Most Transmissible Strain of the Coronavirus in the Country is Also now the Most Prevalent. Here’s What you Need to Know
Become Our Fan On Facebook
Find Us On Facebook


Follow Us On X
Follow Us On X

Editorials

Lakeshia Myers
Michelle Bryant
Dr. Kweku Akyirefi Amoasi formerly known as Dr. Ramel Smith

Journalists

Karen Stokes

Topics

Health Care & Wellness
Climate Change
Upcoming Events
Obituaries
Milwaukee NAACP

Politicians

David Crowley
Cavalier Johnson
Marcelia Nicholson
Governor Tony Evers
President Joe Biden
Vice President Kamala Harris
Former President Barack Obama
Gwen Moore
Milele A. Coggs
Spencer Coggs

Classifieds

Job Openings
Bid Requests
Req Proposals
Req Quotations
Apts For Rent

Contact Us

Milwaukee Courier
2003 W. Capitol Dr.
Milwaukee, WI 53206
Ph: 414.449.4860
Fax: 414.906.5383

Copyright © 2025 · Courier Communications | View Privacy Policy | Site built and maintained by Farrell Marketing Technology LLC
We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.